Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang X W
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4258, USA.
Oncogene. 2007 Sep 27;26(44):6361-71. doi: 10.1038/sj.onc.1210463. Epub 2007 Apr 23.
Tumor cell invasion is a primary event in the metastatic progression of hepatocellular carcinoma (HCC). Our recent results indicate a concordant elevated expression of osteopontin (OPN) and matrix metalloproteinase-9 (MMP-9) in primary metastatic HCC. This study hypothesizes an MMP-9-directed cleavage of OPN that biologically contributes to HCC metastasis. We found that MMP-9 cleaved OPN into specific fragments in vitro, of which three could be identified by Edman degradation amino-acid sequencing. One of these fragments (OPN-5 kDa, residues 167-210) induced low-metastatic HCC cellular invasion via CD44 receptors, which was effectively blocked by the addition of small peptides within the region of OPN-5 kDa. Increased expression of an OPN splice variant (OPN-c) was associated with clinical metastatic HCC. Overexpression of OPN-c with physiological levels of MMP-9 enhanced cellular invasion and coincided with elevated OPN-5 kDa levels. Our data suggest that an alternative splicing event (OPN-c) promotes extracellular cleavage of OPN by MMP-9, thus releasing a distinct region of OPN (OPN-5 kDa) that is essential for HCC cellular invasion and appears to correlate with metastatic potential. The findings of this study may help to improve advanced-stage HCC prognosis and suggest the utility of small peptides for novel therapies.
肿瘤细胞侵袭是肝细胞癌(HCC)转移进展中的首要事件。我们最近的研究结果表明,在原发性转移性HCC中骨桥蛋白(OPN)和基质金属蛋白酶-9(MMP-9)的表达一致升高。本研究推测MMP-9对OPN的切割在生物学上促进了HCC转移。我们发现MMP-9在体外将OPN切割成特定片段,其中三个片段可通过埃德曼降解氨基酸测序鉴定。这些片段之一(OPN-5 kDa,第167-210位氨基酸残基)通过CD44受体诱导低转移性HCC细胞侵袭,而在OPN-5 kDa区域内添加小肽可有效阻断这种侵袭。一种OPN剪接变体(OPN-c)的表达增加与临床转移性HCC相关。在生理水平的MMP-9存在下OPN-c的过表达增强了细胞侵袭,并与OPN-5 kDa水平升高一致。我们的数据表明,一种选择性剪接事件(OPN-c)促进了MMP-9对OPN的细胞外切割,从而释放出OPN的一个独特区域(OPN-5 kDa),该区域对HCC细胞侵袭至关重要,并且似乎与转移潜能相关。本研究结果可能有助于改善晚期HCC的预后,并提示小肽在新型治疗中的应用价值。